Jupiter Neurosciences Introduces Nugevia MND Cognitive Health Supplement

Jupiter Neurosciences introduces Nugevia MND, a cognitive health supplement designed to protect and enhance cognitive function and support overall brain health. MND addresses the consumer demand for clinically validated cognitive wellness solutions, opening up significant market opportunities in the growing $8 trillion longevity and wellness markets.

Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company, has introduced Nugevia MND, a scientifically formulated supplement designed to protect and enhance cognitive function and support overall brain health. The product addresses the surging consumer demand for clinically validated cognitive wellness solutions, opening up significant market opportunities in the rapidly growing $8 trillion longevity and wellness markets [1].

Nugevia MND uniquely combines Jupiter's proprietary JOTROL resveratrol technology, which significantly improves bioavailability and central nervous system penetration, with NovaSOL Curcumin, a highly bioavailable curcumin formulation proven effective in supporting cognitive resilience and neuroprotection. This innovative pairing targets multiple neuroprotective pathways, including reducing oxidative stress, inflammation, and supporting synaptic plasticity, thereby promoting enhanced cognitive health [1].

The introduction of Nugevia MND represents a strategic step in leveraging Jupiter's CNS therapeutic expertise within the consumer health market. "We've worked extensively on our third, and in my opinion the most important, product in the Nugevia launch," stated Christer Rosen, Chairman and CEO of Jupiter Neurosciences. "My mother passed away from Alzheimer's Disease, making this particular product one that holds a deep sense of obligation and importance to me. Additionally, Jupiter's former CFO ultimately lost his fight to Parkinson's Disease. This is personal, this is important, and based on our JOTROL pharmaceutical pre-clinical and clinical data, we are here to bring what we believe is the best cognition product to the market" [1].

Nugevia MND is poised to generate high-margin revenue by targeting adults seeking to maintain and enhance cognitive performance, particularly amidst aging populations increasingly impacted by cognitive decline. The product also strategically complements Jupiter's therapeutic pipeline, creating synergies between consumer and pharmaceutical segments [1].

Key scientifically supported benefits of Nugevia MND include enhanced memory, clarity, and executive function; reduction in neuroinflammation and oxidative stress; support for mitochondrial function in brain cells; and potential protective effects against age-related cognitive decline [1].

Nugevia MND will be commercially available through direct-to-consumer e-commerce platforms starting Fall 2025 as a convenient two-capsule daily regimen [1].

References
[1] Jupiter Neurosciences Introduces Nugevia MND, a Cognitive Health Supplement. Retrieved from https://www.marketscreener.com/news/jupiter-neurosciences-introduces-nugevia-mnd-a-cognitive-health-supplement-leveraging-clinically-va-ce7c51dadb8df024